Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Audentes Therapeutics Inc (NQ: BOLD)
59.97 USD  UNCHANGED
Last Price  /  Updated: 5:31 PM EST, Jan 14, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 59.97
Bid (Size) 59.94 (380)
Ask (Size) 59.99 (1683)
Prev. Close 59.97
Today's Range 59.97 - 59.97
52wk Range 25.41 - 60.00
Shares Outstanding 36,743,621
Dividend Yield N/A
Performance
YTD
+0.23%
+0.23%
1 Month
N/A
N/A
3 Month
+0.22%
+0.22%
6 Month
+127.59%
+127.59%
1 Year
+58.52%
+58.52%
Top News
More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – BOLD, INST, THOR
from GlobeNewswire News Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – BOLD, AKS, INST, THOR
from GlobeNewswire News Releases
More News
Read More
AUDENTES ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of BOLD and Encourages Investors to Contact the Firm
from Business Wire News Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – INST, AKS, BOLD, SORL
from GlobeNewswire News Releases
UPDATE 1-Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 mln
category companyNews
from Reuters: Company News
Astellas Pharma buys Xyphos Biosciences, deal worth up to $665 mln
category companyNews
from Reuters: Company News
UPDATE 2-Roche dives deeper into gene therapy with $1.15 bln Sarepta licensing deal
category companyNews
from Reuters: Company News
TECD, TIF, BOLD, and WLH SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
from GlobeNewswire News Releases
Sarepta’s surprise FDA approval for rare disease drug excites investors
category SPX , Pharmaceuticals , SRPT , and 6 more.
from MarketWatch
BOLD, MDCO, AYR, and PEGI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
from GlobeNewswire News Releases
Drugmakers have spent a record $342 billion on M&A in 2019
category Company Announcements/Warnings , Biotechnology , XBIT , and 19 more.
from MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.